NCT06299163 2025-07-23
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
Numab Therapeutics AG
Phase 1 Terminated
Numab Therapeutics AG
University of Pennsylvania
Multitude Therapeutics Inc.
Sohag University
National Institutes of Health Clinical Center (CC)
Bayer